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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the effects of home-care ’re-ablement’ services compared to usual care, or to a wait list control group, in terms of maintaining
and improving the functional independence of older adults.
B A C K G R O U N D
Description of the condition
As the population ages and people live longer, the proportion
of dependent older people is likely to increase (Brodsky 2003;
Wittenberg 2004). As a result, the cost of long-term care for people
aged over 65 years living in Organisation for Economic Co-op-
eration and Development (OECD) countries is expected to dou-
ble or even triple by 2050 (Oliveira Martins 2006). Therefore,
many high-income countries have actively promoted a shift from
residential to home-based care as a potentially more effective and
financially sustainable approach to meeting the health and social
care needs of older adults (Rostgaard 2011). Importantly, most
older people prefer to ’age in place’ (Wiles 2012) and, therefore, to
remain in their own homes for as long as possible, provided they
have appropriate levels of support to meet their (changing) needs
(Cutchin 2009).
Government policies in various countries reflect the need to recon-
figure health and social service provision in order to meet the cur-
rent and future requirements of an ageing population. In England,
for example, the Department of Health has articulated a vision
for the integration of health and social care services, with a greater
focus on individualised preventative services to delay the need for
more costly forms of care (Xie 2012). Similar themes of early in-
tervention, person-centred care and restoration of function have
emerged in Australia (Cartwright 2009), Sweden (Löfqvist 2012)
and New Zealand (King 2011) mainly with a view to reducing
pressure on the system. However, despite these changes, little is
known about the effectiveness and cost-effectiveness of models of
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care provision across different geographical and socio-economic
contexts.
Description of the intervention
In recent years, there has been increasing international interest in
’re-ablement’ (also known as ‘restorative’ care in Australia and the
USA); an innovative approach to improving home-care services
for older adults in need of care and support or at risk of func-
tional decline.(Francis 2011). There is a lack of clarity regarding
the boundaries between ‘re-ablement’ and other related interven-
tions in health and social care (including intermediate care, occu-
pational therapy and traditional domiciliary care) (Wood 2012).
While ’re-ablement’ shares features with other interventions, it is
distinguished by a re-orientation of home care away from treating
disease and creating dependency to maximising independence, by
offering intensive (i.e. multiple visits) and time-limited (typically
6 to 12 weeks duration), multidisciplinary, person-centred, and
goal-directed home-care services (Ryburn 2009). It is important
to note that ‘re-ablement’ is not designed to resolve specific health
care issues (for exampleCrotty 2010), butmay help anolder person
to regain confidence and functional abilities after recovering from
an illness or a period of hospitalisation. Therefore, a ‘re-ablement’
programme typically includes a range of targeted components de-
signed to optimise functioning in the performance of activities
of daily living. These may include exercise and training support-
ing behavioural change, education about self-management and
healthy ageing, environmental adjustments, provision of equip-
ment, and use of local resources (Kent 2000; Tinetti 2002; Lewin
2010). So, for example, rather than providing a meals-on-wheels
service, a ‘re-ablement’ approach would enable an older person to
develop the confidence and skills to prepare lunch through task
analysis and redesign, the use of assistive technology and physical
exercises (Glendinning 2010).
‘Re-ablement’, therefore, contrasts with usual home care/domicil-
iary care which tends to focus on doing things for older people
rather than enabling/re-abling them to do things for themselves.
Indeed, traditional models of home care have been shown to in-
crease dependency, with an associated loss of function (Parsons
2013). Furthermore, the assumption underpinning usual home-
care services is that they will continue indefinitely (Montgomery
2008), whereas ’re-ablement’ is specifically time-limited and aims
to reduce the need for home care into the future (Ryburn 2009;
King 2011). ‘Re-ablement’, therefore, is particularly valued for its
potential to decrease demand on home-care services and to reduce
the attendant costs of ongoing care (Jones 2009). Nevertheless,
this form of care provision may have considerable resource impli-
cations in terms of re-training staff and effecting organisational
change (Francis 2011).
The ‘re-ablement’ approach has become increasingly popular and
has been implemented widely in the UK (Department of Health
2010) and adopted in a number of other countries (e.g., New
Zealand (King 2011; Parsons 2013), Australia (Ryburn 2009),
USA (Tinetti 2002)). The provision of ‘re-ablement’ reflects a
wider change agenda that promotes person-centred care through
individually tailored services that permit greater choice and control
for consumers (Xie 2012). Additionally, the growth in this type of
approach is in line with the increasing demands of people as they
age; older consumers are becoming increasingly likely to demand
greater choice,more personalised services and better quality home-
care support in the future (Rostgaard 2011).
How the intervention might work
The ‘re-ablement’ approach emphasises the active participation of
an older person in working towards agreed goals that are designed
to maximise independence and confidence. For example, these
goalsmight include re-gaining confidence in self-caremanagement
and improving mobility. The content of the intervention may
encompass graduated practice in completing tasks, environmental
adjustments, and adaptive equipment, or enabling an older person
to build up social networks (Ryburn 2009). Improved outcomes
across similar domains, including self-care, mobility and quality of
life have been reported (Kent 2000; Tinetti 2002). Furthermore,
the ability to function effectively in the home may reduce the
need for unscheduled hospital admission, and postpone or prevent
admission to residential care (Tinetti 2002). A reduction in the
care hours required following the intervention is frequently used
as a measure of success (Kent 2000; Lewin 2010) although this
may not always be a desired or possible outcome for some older
people, particularly those who are socially isolated or in failing
health (Francis 2011). Arguably, therefore, a decrease in hours of
care with regard to older people with high dependency needs may
not be an appropriate outcome measure. Importantly, additional
outcomes that are valued by older people themselves as indicators
of effective services should be measured (Clark 2001).
The route and threshold for entry into a ‘re-ablement’ based ser-
vice varies. Some hospital discharge support schemes select only
older people who are most likely to benefit from the approach
(i.e. people with relatively low levels of ongoing need), whereas
a ‘re-ablement’ service that takes referrals directly from the com-
munity may adopt a more flexible approach and screen out only
those people who are terminally ill or who have advanced dementia
(Glendinning 2010). Nevertheless, it seems likely that outcomes
will vary depending on the route of entry and also on the func-
tional abilities of the older person on entry to the service. For in-
stance, those with a high level of need may not benefit as much
as those with lower support requirements (Francis 2011). Indeed,
‘re-ablement’ represents only one end of the continuum of care
and may not be suitable for people with chronic or relatively in-
tractable problems such as dementia, who may require a different
type of longer term service model (CSED 2007).
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Why it is important to do this review
In recent years, there has been strong international interest in
developing effective and cost-effective interventions to support
older people living in their own homes and, in turn, to reduce the
demand on acute hospital services and residential care provision. It
has been argued that a lack of (or poorly developed) rehabilitation
services has contributed to increasing pressure on acute hospital
beds, delayed discharge, more frequent re-admissions to hospital
and increased use of costly residential and nursing home care (
Audit Commission 2000). One approach to ‘freeing up’ hospital
beds is to support early discharge by providing acute care at home.
For example, a Cochrane review (Shepperd 2011) of ‘hospital at
home’ services found that older patients with a mix of conditions
were less likely to need residential care at follow-up after receiving
these services, although only a small proportion of older people
were deemed to be eligible or were willing to take part.
There is currently limited evidence as to which setting or model(s)
of care may be most effective for the rehabilitation and mainte-
nance of older adults’ independence (Huss 2008; Ward 2009).
This appears to be due, in large part, to the challenges involved
in comparing different interventions containing multiple compo-
nents across a range of settings. For example, Beswick 2008 and
Huss 2008 reviewed a range of heterogenous studies (n = 89 and
n = 21 respectively) such as community-based nursing care fol-
lowing discharge from hospital, falls prevention, group education
and annual health assessments. The reviews concluded that while
multidimensional home-based programmes had the potential to
reduce the burden of disability among older adults, it was not
possible, on the basis of the available evidence, to identify which
one of the various models/types of care provision was the most
effective. There is a need to undertake a focused systematic review
in order to assess the comparative effectiveness and disentangle
the effects of each type of intervention and their potentially active
ingredients or components.
Whilst a number of previousCochrane and non-Cochrane reviews
have examined a range of rehabilitation and home-visiting pro-
grammes, there has not, as yet, been a systematic review that has
focused specifically on the effects of ’re-ablement’-based interven-
tions. Important questions about the effectiveness and cost-effec-
tiveness of these types of interventions remain unanswered. For
example, does ’re-ablement’ reduce health service utilisation (such
as hospital re-admissions), do specific subgroups benefitmore than
others (e.g., younger populations, and those with lower levels of
need), and is there evidence to support personalisation of the ser-
vice? Thus, this reviewwill address an important gap in our knowl-
edge.
O B J E C T I V E S
To assess the effects of home-care ’re-ablement’ services compared
tousual care, or to await list control group, in terms ofmaintaining
and improving the functional independence of older adults.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials, cluster randomised trials and quasi-
randomised controlled trials of ’re-ablement’ compared to ’usual
care’ (i.e., home-care support, whichmay include unpaid informal
care) or wait list.
The inclusion of cluster randomised and quasi-randomised trials
is deemed necessary in order to consider trials where individual
random assignment may have been impractical due to the nature
of the intervention (e.g., only the ’re-ablement’ intervention is
available in one geographical area or there may be restrictions in
terms of the availability of care staff to deliver either ‘re-ablement’
or usual care).
We will also include studies examining the costs or cost-effective-
ness of the intervention versus usual care which have been con-
ducted alongside, or subsequent to, trials that meet the eligibility
criteria (Shemilt 2011).
Types of participants
Older adults aged 65 years or older living in their own home who
require assistance to perform tasks of daily living and to participate
in normal activities due to poor physical or mental health. We
will exclude trials involving older adults living outside their own
homes (e.g. in nursing homes).
We may encounter trials with mixed populations in which case
we will include trials with more than 80% of older adults (≥ 65
years) in the overall sample. We will include trials if data about
older adults can be disaggregated for analysis. Study authors will
be contacted, if necessary, for additional information.
Types of interventions
’Re-ablement’ interventions will be compared with groups receiv-
ing usual home-care services or with a wait list control group.
Studies will be required to meet all of the following criteria:
1. participants must have an identified need for formal care
and support or are at risk of functional decline (Francis 2011)
2. the intervention must be time-limited (typically 6 to 12
weeks) and intensive (e.g., multiple home visits) (Ryburn 2009);
3. the intervention must be delivered in the older person’s own
home (Glendinning 2010);
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4. the intervention must focus on maximising independence;
and
5. the intervention must be person-centred and goal-directed
(Parsons 2013).
We will exclude trials that focus on the provision of acute care
(e.g., nursing care in the home), and those describing interventions
outside of existing home-care services.
The control group will be in receipt of, or awaiting, usual home-
care services, defined as ongoing assistance with completion of
household activities and/or personal care by an outside agency
(i.e., paid support) and/or informal (unpaid) care, with or with-
out professional input (e.g., nurses, occupational therapists). The
control group may also include those waiting for the intervention
(wait list).
Types of outcome measures
We recognise the possibility that specific outcomes may be mea-
sured using different tools across trials. If this is the case we will
select the primary outcome identified by the publication authors.
Where no primary outcome has been identified, we will select the
one specified in the sample size calculation. If there are no sample
size calculations, we will rank the effect estimates and select the
median effect estimate.
We will only include studies which have measured functional out-
comes (e.g., activities of daily living).
Primary outcomes
1. Functional status including independent living, and ability
to complete activities of daily living (measured using scales, such
as Barthel Index of Daily Living or Lawton & Brody Scale; we
will also consider studies which use unvalidated measures).
2. Adverse events including mortality, hospital (re)admission.
Secondary outcomes
• Quality of life. We will evaluate studies that assess health
and/or social care-related quality of life (HRQoL; SCRQoL)
using validated uni- or multi-dimensional questionnaires.
Examples of generic HRQoL questionnaires include the SF-36
and EQ-5D; SCRQoL measures include ASCOT (Adult Social
Care Outcome Toolkit; Netten 2011).
• User satisfaction
• Service outcomes, including level of ongoing home care
service (e.g. care hours) or use of external health services.
• Living arrangements (i.e., in own home or other setting).
• Cost effectiveness (as measured by comparing the costs of
the intervention versus ’usual care’; and health service
utilisation). Incremental Cost-Effectiveness Ratios (ICER) are a
central component of full economic evaluations. However, full
economic evaluations of ‘re-ablement’ interventions may be
relatively rare (e.g., Pilkington 2011) and as such, we will also
search for studies that include only costs data as long as these
have been conducted alongside, or subsequent to, trials that meet
the eligibility criteria.
Timing of outcome assessment
All outcomes will be measured at baseline and on ‘discharge’ from
the ’re-ablement’ service (typically 6 to 12 weeks). Follow-ups of 6
and 12 months will also be analysed when such data are available.
Main outcomes for ’Summary of findings’ table
We will prepare a ’Summary of findings’ table to present the re-
sults of the meta-analysis, based on the methods described in
theCochrane Handbook (Schünemann 2011). We will present the
results of meta-analysis for the major comparisons of the review
for the following main outcomes:
• functional status
• adverse events
• quality of life
• level of ongoing service use
• living arrangements (i.e., living in own home or elsewhere)
• cost-effectiveness
Search methods for identification of studies
We will identify studies through key word and text word searches
of relevant electronic databases and government and non-govern-
ment agencies, as well as searching grey literature (including con-
ference papers, unpublished theses, reference lists of other reha-
bilitation reviews) and personal communications with experts in
the field.
Electronic searches
We will search the following electronic databases:
• Cochrane Central Register of Controlled Trials
(CENTRAL, The Cochrane Library)
• MEDLINE (Ovid SP)
• EMBASE (Ovid SP)
• PsycINFO (Ovid SP)
• ERIC
• Sociological Abstracts
• SCOPUS
• Proquest Dissertations and Theses database
• CINAHL (EBSCOhost)
• SIGLE (System for Information on Grey Literature in
Europe)
• Campbell Collaboration’s Social, Psychological,
Educational and Criminological Trials Register
• AgeLine
• Social Care Online (Social Care Institute for Excellence)
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• WHO International Clinical Trial Registry
• ClinicalTrials.gov
The MEDLINE (OvidSP) strategy is shown in Appendix 1. This
will be modified as necessary for use with other databases. No date
restrictions will be applied to the searches.
Searching other resources
Wewill contact key experts in the field and first authors of included
studies for advice as to other relevant published, unpublished and
ongoing studies (e.g. conference papers, unpublisheddissertations,
working papers or government reports) that should be included.
We will also search reference lists of included studies and relevant
reviews to identify further relevant studies.
Data collection and analysis
Selection of studies
One review author (AC) will read the titles and abstracts of the
identified references and eliminate any studies that are deemed
to be immediately irrelevant. Two review authors (AC and MF)
will discuss any abstracts about which the first author is uncertain.
We will then obtain the full text of the remaining studies and,
based on the Criteria for considering studies for this review, two
review authors (AC and MF) will independently rank these as
’includes’ or ’excludes’. In the event of a disagreement, we will seek
consensus through discussion and involving a third review author
(SMcG) if necessary. We will contact study authors for further
information if the eligibility of the study for inclusion is unclear.
We will also provide citation details and any available information
about ongoing studies, and collate and report details of duplicate
publications, so that each study (rather than each report) is the unit
of interest in the review. We will report the screening and selection
process in an adapted PRISMA flow chart (Liberati 2009).
Data extraction and management
Two review authors (AC and MF) will independently extract data
from the original reports using a data extraction form adapted
from the Data Extraction Template provided by the Cochrane
Consumers and Communication Review Group. We will pilot
the adapted form on a small sample of studies (n = 5) before
finalising the design. Any disagreement between the review authors
in relation to data extraction will be resolved by discussion and
consensus, and following discussion with a third review author if
necessary.
Data to be extracted will include the following items:
• General: author, year of publication, title, journal, country
and language of publication; funding source and declaration of
interest
• Trial: study design (RCT, Cluster-RCT, quasi-RCT)
• Participant: diagnosis/health status, age, gender, ethnicity,
living situation (e.g., alone, with other); sample size; method of
recruitment (post-hospital discharge or from the community);
inclusion and exclusion criteria
• Intervention: components of intervention (e.g., exercise,
task redesign; assistive technology; education); assessment and
care planning; involvement of older people in goal setting; care
planning process; composition of ‘re-ablement’ team and
training; health professionals involved; other services used;
length of intervention; frequency of contact; length of follow-up;
implementation fidelity
• Control: assessment and care planning; composition of
team and training; health professionals involved; other services
used; length of intervention; frequency of contact
• Methodological quality elements for Assessment of risk of
bias in included studies
• Outcomes: functional status (tools used), adverse event;
where living; level of service need; health service utilisation
including attendance at emergency department, (re-
)hospitalisation, family doctor visits; nursing home placement;
satisfaction; timing of outcome assessment(s).
All extracted data will be entered into RevMan by one review au-
thor (AC) and will be checked for accuracy against the data ex-
traction sheets by a second review author (MF) working indepen-
dently.
Assessment of risk of bias in included studies
We will assess and report on the methodological risk of bias
of included studies in accordance with the Cochrane Handbook
(Higgins 2011) and the guidelines of the Cochrane Consumers
and Communication Review Group (Ryan 2011). These recom-
mend the explicit reporting of the following elements for RCTs:
random sequence generation; allocation sequence concealment;
blinding (participants and personnel); blinding (outcome assess-
ment); completeness of outcomedata (includingdata on attrition);
selective outcome reporting; and other sources of bias (e.g., base-
line comparability; reporting biases (see Assessment of reporting
biases)). For cluster-RCTs we will also assess and report the risk
of bias associated with selective recruitment of cluster participants
and potential contamination between intervention and control
group. In addition, we will assess and report quasi-RCTs as being
at a high risk of bias on the random sequence generation item of
the ’Risk of bias’ tool.
We will judge each item and outcome separately as being at high,
low or unclear risk of bias as set out in the criteria provided by
Higgins 2011 and we will provide a quote from the study report
and a justification for our judgement for each item in the ’Risk of
bias’ table. In all cases, two authors (AC and MF) will indepen-
dently assess the risk of bias of included studies, with any disagree-
ments resolved by discussion and consensus. We will contact study
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authors for additional information about the included studies, or
for clarification of the study methods as required. We will incor-
porate the results of the ’Risk of bias’ assessment into the review
through standard tables, and systematic narrative description and
commentary about each of the elements. All of this information
will be used to inform the overall assessment of the risk of bias
of included studies and a judgement about the internal validity of
the review results.
With regard to the cost-effectiveness analysis, the ’Drummond
checklist’ will be used, in conjunction with the NHS EED struc-
tured abstract, where available, to critically appraise the method-
ological quality of included health economic studies (Shemilt
2011).
Measures of treatment effect
Dichotomous data
For dichotomous variables (e.g., living at home versus other lo-
cation), we will calculate relative risks (RR) and their 95% con-
fidence intervals (CI) comparing the intervention to the control
group for each included study.
Continuous data
Continuous data (e.g., quality of life scores) will be analysed if
means and standard deviations are available, or if there is some
other way to calculate effect size (e.g. from t-tests, F-tests, or exact
P values). If reports have insufficient data, additional information
will be requested from the authors.
Where scales measure the same clinical outcomes (e.g. functional
status) in different ways, standardised mean differences (SMD) or
Cohen’s d will be estimated using RevMan’s formula for SMD;
this is based on Hedges’ g which includes an adjustment for small
sample bias. A mean difference will be used where studies employ
the same measures. Confidence intervals of 95% will be used for
individual study data and pooled estimates throughout. Studies
that provide both dichotomous and continuous measures of the
same construct will be analysed separately.
Time-to-event data
For time-to-event (e.g., transfer to nursing home) data, we will
extract the log of the hazard ratio (log(HR)) and its standard error
from trial reports. If these are not reported, we will attempt to
estimate the log(HR) and its standard error using published meth-
ods (Parmar 1998; Tierney 2007). HRs will be pooled using the
generic inverse-variance method of RevMan 5.2 (Deeks 2011).
Economic data
The characteristics of any health economic studies to be included
in the review will be tabulated by subgroups (i.e. full economic
evaluations, partial economic evaluations, and analyses reporting
more limited information). These studies will be assessed for risk
of bias using theDrummond checklist before a decision is made to
pool any studies, particularly in relation to whether the metric in
question has equivalent meaning across studies (Shemilt 2011). In
circumstances where there is evidence of little variation in resource
or cost use between studies, it may be regarded as legitimate to
present a pooled estimate. Otherwise we will clearly present the
distribution of costs (Shemilt 2011).
If a decision is made to conduct meta-analyses of resource use or
cost data, this will be supported, firstly, by a thorough critical ap-
praisal of the methods used to derive such estimates within the
corresponding health economics studies and, secondly, by the use
of 95% confidence intervals and statistical methods to assess be-
tween-study heterogeneity (e.g. I2 statistic, Chi2 test, random-ef-
fects models). Cost estimates collected from multiple studies will
be adjusted to a common currency and price year before these data
are pooled. Careful consideration will be given to the jurisdiction,
analytic perspective and time horizon for both costs and effects.
If meta-analyses of resource use or cost data are conducted, a nar-
rative summary will be included in the Results section to com-
ment on the direction and magnitude of results and their preci-
sion. Similarly, if two or more health economics studies are in-
cluded in a review, but a decision is taken not to pool (in a meta-
analysis) resource use and/or cost data, this will be stated in the
Methods section (Shemilt 2011). If we are not able to pool data
we will include a narrative summary of included studies including
the design and analytical viewpoints adopted, the primary out-
come measure used for the evaluation, resource use and unit cost
data, and the generalisability of the conclusions drawn for other
jurisdictions (Drummond 1996).
Unit of analysis issues
Trials may include results from more than one time-point (e.g.
end of intervention at 6 to 12 weeks, and follow-up at 6 months,
and 1 year). In such instances, separate analyses will be conducted,
based on the different time frames and relevant outcomes. Any
relevant cluster-RCTs that are identified will be analysed using
the methods described in theCochrane Handbook (Higgins 2011).
If cluster-RCTs are included we will check for unit-of analysis
errors. If errors are found and sufficient information is available,
we will re-analyses the data using the appropriate unit of analysis
by taking account of the intracluster co-efficient (ICC). We will
contact study authors of included studies to obtain ICC estimates
if these are not clearly available from the trial reports, or impute
them using estimates from external sources (i.e., from a study of a
similar population). If ICCs fromother sources are used, sensitivity
analyses to investigate the effect of variation in the ICC will be
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conducted and reported. If it is not possible to obtain sufficient
information to reanalyse the data we will report the effect estimate
and annotate ’unit-of-analysis error’.
Dealing with missing data
If data are missing from the relevant comparisons, we will contact
the study authors to obtain the information.Missing data and drop
outs/attritionwill be assessed for each study and reported in a ‘Risk
of bias’ table. Numbers, reasons and characteristics of drop outs
will be assessed and reported. Anymeta-analysis will use data from
all originally randomised participants where possible. If missing
data are not available, a sensitivity analysis will be conducted by
excluding studies with 20% or more of data missing for one of
the primary outcomes, to assess potential bias in the analysis. The
extent to which the results might be biased by missing data will
also be discussed.
Assessment of heterogeneity
Where studies are considered sufficiently similar (for example
based on considerations of population, invention duration and in-
tensity) to allow pooling of data using meta-analysis, we will assess
the degree of heterogeneity by the visual inspection of forest plots
and by examining the Chi2 test for heterogeneity. Heterogeneity
will be quantified by using the I2 statistic (Higgins 2011). An I2
value of 50% or more will be considered to represent substantial
heterogeneity, but this value will be interpreted in light of the size
and direction of effects and the strength of the evidence of het-
erogeneity based on the P value from Chi2 test (Higgins 2011).
If there is evidence of heterogeneity, authors will discuss possible
reasons and conduct subgroup analyses accordingly; the issue of
sample size and power in each study will be considered in the in-
terpretation and reporting of the results.
Where we detect substantial clinical, methodological or statistical
heterogeneity across included studies we will not report pooled
results frommeta-analysis but will instead use a narrative approach
to data synthesis. In this event we will attempt to explore possible
clinical or methodological reasons for this variation by grouping
studies that are similar in terms of features of the intervention
(e.g., duration) and methodological features (e.g., study design)
to explore differences in intervention effects.
Assessment of reporting biases
We will assess reporting bias qualitatively based on the character-
istics of the included studies (e.g., if only small studies that indi-
cate positive findings are identified for inclusion), and if informa-
tion that we obtain from contacting experts and authors or studies
suggests that there are relevant unpublished studies. If we iden-
tify sufficient studies (at least 10) for inclusion we will construct
funnel plots to investigate any relationship between effect size and
standard error. Such a relationship could be due to publication or
related biases, or due to systematic differences between small and
large studies. Where such a relationship is identified, the method-
ological diversity of the studies will be further examined as a pos-
sible explanation (Egger 1997). Findings will be incorporated into
the ’Risk of bias’ tables under ’Other sources of bias’.
Data synthesis
Wewill decide whether to meta-analyse data based on whether the
included trials are sufficiently similar enough in terms of partic-
ipants, interventions, comparisons and outcome measures to en-
sure meaningful conclusions from a statistically pooled result. We
will only combine cluster RCTs with individual RCTs, if any unit-
of-analysis errors have been addressed. Due to the anticipated vari-
ability in the intervention and participants of included studies we
will use a random-effects model for meta-analysis. Data synthesis
will be conducted using ReviewManager (RevMan) 5.2, the latest
version of the Cochrane Collaboration’s meta-analysis software.
If we are unable to pool the data statistically using meta-analysis
we will present a narrative summary of the findings. Depending
on the number of studies these will be organised into categories
or clusters (e.g., study design) that best explore the heterogeneity
of the studies. We will also explore the main comparisons of the
review: intervention versus usual care; intervention versus no in-
tervention/wait list. The findings will be presented in a ’Summary
of findings’ table format so that it will be easier to identify any
patterns in the results.
Subgroup analysis and investigation of heterogeneity
Further investigations of the causes of heterogeneity may be con-
ducted using subgroup analysis; this will be based on the following
subgroup parameters (where available) that have emerged from
the literature:
• Context of recruitment to intervention (i.e. after hospital
discharge or from within the community): we anticipate that the
participants who have been recently discharged from hospital
may have a higher level of need and/or be at greater risk of re-
admission than those recruited from the community, and thus
some differences in outcomes may emerge (Francis 2011).
• Mean age of participants: there is some indication that
younger participants (i.e., under 75 years) may gain greater
benefit from ‘re-ablement’. We therefore will examine two
groups: (1) people aged 65 to 75, and (2) people aged over 75, to
explore this effect (Glendinning 2010).
• Living circumstances (i.e. alone or with others): isolated
older people may experience the service differently from those
with a higher level of social support (Francis 2011).
• Duration of intervention: defined as ’standard’ = 6 weeks;
’long’ = 7 to 12 weeks; some trials may offer an extended period
of ‘re-ablement’ to meet individual needs (Jones 2009).
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Sensitivity analysis
We will perform sensitivity analyses to evaluate the robustness of
the pooled effect sizes across various components of methodolog-
ical quality in order to see how robust the various effect estimates
are. We will analyse the effects of excluding trials that are judged
to be at high risk of bias across one or more of the domains of se-
quence generation, allocation concealment, attrition (rates larger
than 20%) and outcome reporting (greater than 20% of data miss-
ing) for the meta-analysis of the primary outcomes. If the exclu-
sion of trials at high risk of bias does not substantially alter the
direction of effect or the precision of the effect estimates, then
we will include data from these trials in the analysis. We will also
undertake a sensitivity analysis to assess the effects of including
data from trials where we used imputed values (e.g., ICC values
from external sources for cluster-RCT trials).
’Summary of findings’ table
Outcomes to be reported in a ’Summary of findings’ table are
listed at Types of outcome measures. We will provide a source
and rationale for each assumed risk cited in the table(s), and two
authors will independently assess the quality of the evidence as
implemented and described in the GRADEprofiler (GRADEpro)
software (Schünemann 2011). If meta-analysis is not possible, we
will present results in a narrative ’Summary of findings’ table for-
mat such as that used by Chan 2011.
Consumer participation
‘Re-ablement’ reflects a partnership between the older person and
the service providers, and thus consumer participation in this re-
view is considered important. We will therefore invite consumer
referees to comment on the protocol and on the completed re-
view through Cochrane Consumers and Communication Review
Group editorial processes.
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A P P E N D I C E S
Appendix 1. MEDLINE Search Strategy
OvidSP
1. home care services/
2. (home adj5 (care or visit*)).tw.
3. homecare.tw.
4. house calls/
5. domiciliary care.tw.
6. own home?.tw.
7. (community dwelling or community setting or living in the community or home based).tw.
8. community health nursing/
9. or/1-8
10. exp rehabilitation/
11. (rehab* or (activit* adj2 daily living)).tw.
12. (re-abl* or reabl* or enablement or empower* or restor* or re-learn* or relearn*).tw.
13. “recovery of function”/
14. ((recover* or optim* or maintain* or increas* or improv* or independen* or ability or outcome*) adj3 function*).tw.
15. ((enabl* or recover* or maintain* or develop* or living) adj3 independen*).tw.
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16. self care/
17. (self adj (care or manag*)).tw.
18. or/10-17
19. 9 and 18
20. randomized controlled trial.pt.
21. controlled clinical trial.pt.
22. randomized.ab.
23. placebo.ab.
24. drug therapy.fs.
25. randomly.ab.
26. trial.ab.
27. groups.ab.
28. or/20-27
29. exp animals/ not humans.sh.
30. 28 not 29
31. 19 and 30
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